Delivery of atovaquone and proguanil across sublingual membranes, in vitro

References

• Wernsdorfer WH. Pharmacology and use of selected fixed-dose combinations of antimalarial drugs. (Online) 2008. Available at: http://www.emro.who.int/rbm/Background%20Documents/WHODrugs1.doc. Accessed on 29 January 2009.
   Google Scholar
• CDC. Treatment of Malaria (Guidelines for Clinicians). (Online) 2007. Available at: http://www.cdc.gov/malaria/diagnosis_treatment/clinicians2.htm. Accessed on 4 February 2009.
   Google Scholar
• Lalloo DG, Shingadia D, Pasvol G, Chiodini PL, Whitty CJ, Beeching NJ et al.; HPA Advisory Committee on Malaria Prevention in UK Travellers. UK malaria treatment guidelines. J Infect 2007;54:111–121.
   PubMed Web of Science ®Google Scholar
• WHO and UNICEF. (2003). The Africa Malaria Report. (Online) 2003. Available at: http://www.rollbackmalaria.org/amd2003/amr2003/pdf/amr2003.pdf. Accessed on 12 February 2009.
   Google Scholar
• WHO. Guidelines for the treatment of malaria. (Online) 2006. Available at: http://whqlibdoc.who.int/publications/2006/9241546948_text_eng.pdf Accessed on 6 February 2009.
   Google Scholar
• Roll Back Malaria. Global Malaria Action Plan. (Online) 2008. Available at: http://www.rollbackmalaria.org/gmap/gmap.pdf. Accessed on 12 February 2009.
   Google Scholar
• Deressa W, Ali A, Enqusellassie F. Self-treatment of malaria in rural communities, Butajira, southern Ethiopia. Bull World Health Organ 2003;81:261–268.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhang J, Streisand JB. Oral mucosal drug delivery: Clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet 2002;41:661–680.
   PubMed Web of Science ®Google Scholar
• Wight LJ, VandenBurg MJ, Potter CE, Freeth CJ. A large scale comparative study in general practice with nitroglycerin spray and tablet formulations in elderly patients with angina pectoris. Eur J Clin Pharmacol 1992;42:341–342.
   PubMedGoogle Scholar
• Ducharme A, Dupuis J, McNicoll S, Harel F, Tardif JC. Comparison of nitroglycerin lingual spray and sublingual tablet on time of onset and duration of brachial artery vasodilation in normal subjects. Am J Cardiol 1999;84:952–4, A8.
   PubMedGoogle Scholar
• Squier CA, Wertz PW. Structure and function of the oral mucosa and implications for drug delivery. In: Rathbone MJ, ed. Oral Mucosal Drug Delivery. New York: Marcel Dekker 1996, pp. 1–26.
   Google Scholar
• Ong CM, Heard CM. Permeation of quinine across sublingual mucosa, in vitro. Int J Pharm 2009;366:58–64.
   PubMed Web of Science ®Google Scholar
• Hansson AG, Mitchell S, Jatlow P, Rainey PM. Rapid high-performance liquid chromatographic assay for atovaquone. J Chromatogr B, Biomed Appl 1996;675:180–182.
   PubMed Web of Science ®Google Scholar
• US Pharmacopeia 29. 2005. Reference tables. Available online at http://www.pharmacopeia.cn/v29240/usp29nf24s0_alpha-2-10.html. Accessed on 05/02/09.
   Google Scholar
• BASF Aktiengesellschaft. Cremophor® EL Technical Leaflet. (Online) 1997. Available at: http://www2.zzu.edu.cn/syzx/lijx/cremophorel.pdf. Accessed on 2 March 2009.
   Google Scholar
• Thacharodi D, Rao, KP. Transdermal absorption of nifedipine from microemulsions of lipophilic skin penetration enhancers. Int J Pharm 1994;111:235–240.
   Web of Science ®Google Scholar
• Martindale 32nd Edn. Pharmaceutical Press: London, 1999. pp. 579–580.
   Google Scholar
• National Institute for Occupational Safety and Health (NIOSH). International Chemical Safety Card for N-methyl-2-pyrrolidone. (Online) 1997. Available at: http://www.cdc.gov/niosh/ipcsneng/neng0513.html. Accessed on 19 March 2009.
   Google Scholar
• Saillenfait AM, Gallissot F, Langonné I, Sabaté JP. Developmental toxicity of N-methyl-2-pyrrolidone administered orally to rats. Food Chem Toxicol 2002;40:1705–1712.
   PubMed Web of Science ®Google Scholar
• Office of Environmental Health Hazard Assessment. Proposition 65 maximum allowable dose level (MADL) for reproductive toxicity for N-methylpyrrolidone for dermal and inhalation exposures. (Online) 2003. Available at: http://209.85.229.132/search?q=cache:dmYj9I3MlUQJ:oehha.ca.gov/prop65/law/pdf_zip/NMPMADL31403.pdf±madl±of±n-methyl-2-pyrrolidone±office±of±environmental±health&cd=1&hl=en&ct=clnk&gl=uk. Accessed on 20 March 2009.
   Google Scholar
• Rathbone MJ, Ponchel G, Ghazali FA. Systemic oral mucosal delivery and delivery systems. In: Rathbone MJ, ed. Oral Mucosal Drug Delivery. New York: Marcel Dekker 1996, pp. 241–285.
   Google Scholar
• Lindegårdh N, Blessborn D, Bergqvist Y. Simultaneous quantitation of the highly lipophilic atovaquone and hydrophilic strong basic proguanil and its metabolites using a new mixed-mode SPE approach and steep-gradient LC. J Chromatogr Sci 2005;43:259–266.
   PubMedGoogle Scholar
• Barnes KI, Lindegardh N, Ogundahunsi O, Olliaro P, Plowe CV, Randrianarivelojosia M, Gbotosho GO, Watkins WM, Sibley CH, White NJ. World Antimalarial Resistance Network (WARN) IV: Clinical pharmacology. Malaria J 2007;6:201.
   Google Scholar
• Sabchareon A, Attanath P, Phanuaksook P, Chanthavanich P, Poonpanich Y, Mookmanee D et al. Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 1998;92:201–206.
   PubMed Web of Science ®Google Scholar
• McCall RE, Tankersley CM. Appendix D Laboratory Mathematics. In: McCall RE, Tankersley CM, eds. Phlebotomy Essentials. London: Wolters Kluwer Health 2007:A23–30.
   Google Scholar
• Patani GA, Chien YW. Transdermal drug delivery devices: System design and composition. In: Swarbrick J, Boylan JC, eds. The Encyclopedia of Pharmaceutical Technology. London: CRC Press 2002, pp. 309–338.
   Google Scholar
• Suwanpidokkul N, Thongnopnua P, Umpraym K. The effects of vehicles, enhancers and polymer membrane on permeation of zidovudine (AZT) across cadaver pig skin. Int Conf AIDS 2004:15:11–16.
   Google Scholar
• Kadir R, Stempler D, Liron Z, Cohen S. Delivery of theophylline into excised human skin from alkanoic acid solutions: A “push-pull” mechanism. J Pharm Sci 1987;76:774–779.
   PubMed Web of Science ®Google Scholar
• Heard CM, Kung D, Thomas CP. Skin penetration enhancement of mefenamic acid by ethanol and 1,8-Cineole can be explained by the ‘pull’ effect. Int J Pharm 2006;321:167–170.
   PubMed Web of Science ®Google Scholar
• Raes A, Van Aken S, Craen M, Donckerwolcke R, Vande Walle J. A reference frame for blood volume in children and adolescents. BMC Pediatrics 2006;6:3.
   PubMedGoogle Scholar
• British National Formulary. 56th Edn. Pharmaceutical Press: London, 2008.
   Google Scholar
• Rolan PE, Mercer AJ, Tate E, Benjamin I, Posner J. Disposition of atovaquone in humans. Antimicrob Agents Chemother 1997;41:1319–1321.
   PubMedGoogle Scholar
• Medicines Compendium. (Online) 2009. Available at: www.medicines.org.uk. Accessed on 18 March 2009.
   Google Scholar
• Benet LZ, Kroetz DL, Sheiner LB. Pharmacokinetics: The dynamics of drug absorption, distribution and elimination. In: Hardman JG, Limbird LE, eds. The Pharmacological Basis of Therapeutics. New York: McGraw-Hill 1996:3–27.
   Google Scholar